Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beyersmann

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine TumorsMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Haematologica|June 9, 2018
Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effectsDaniel Fuerst, Sandra Frank, Carlheinz Mueller, et al.
JAMA Neurology|January 19, 2019
Outcomes of Hypothermia in Addition to Decompressive Hemicraniectomy in Treatment of Malignant Middle Cerebral Artery Stroke: A Randomized Clinical TrialHermann Neugebauer, Hauke Schneider, Julian Bösel, et al.
Trials|June 30, 2021
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risksRegina Stegherr, Claudia Schmoor, Jan Beyersmann, et al.
BMJ Evidence-Based Medicine|January 29, 2020
Assessment of assumptions of statistical analysis methods in randomised clinical trials: the what and howAnders Kehlet Nørskov, Theis Lange, Emil Eik Nielsen, et al.
BMJ Evidence-Based Medicine|April 6, 2019
Assessing assumptions for statistical analyses in randomised clinical trialsEmil Eik Nielsen, Anders Kehlet Nørskov, Theis Lange, et al.
Pharmaceutical Statistics|November 21, 2018
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapiesSteffen Unkel, Marjan Amiri, Norbert Benda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2018
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-NetMarlieke E A de Kraker, Harriet Sommer, Femke de Velde, et al.
Blood Advances|October 5, 2024
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in GermanyAysenur Arslan, Svenja Labuhn, Elisa Sala, et al.
European Heart Journal|January 29, 2019
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trialMartina Rothenbühler, Marco Valgimigli, Ayodele Odutayo, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine TumorsMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Haematologica|June 9, 2018
Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effectsDaniel Fuerst, Sandra Frank, Carlheinz Mueller, et al.
JAMA Neurology|January 19, 2019
Outcomes of Hypothermia in Addition to Decompressive Hemicraniectomy in Treatment of Malignant Middle Cerebral Artery Stroke: A Randomized Clinical TrialHermann Neugebauer, Hauke Schneider, Julian Bösel, et al.
Trials|June 30, 2021
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risksRegina Stegherr, Claudia Schmoor, Jan Beyersmann, et al.
BMJ Evidence-Based Medicine|January 29, 2020
Assessment of assumptions of statistical analysis methods in randomised clinical trials: the what and howAnders Kehlet Nørskov, Theis Lange, Emil Eik Nielsen, et al.
BMJ Evidence-Based Medicine|April 6, 2019
Assessing assumptions for statistical analyses in randomised clinical trialsEmil Eik Nielsen, Anders Kehlet Nørskov, Theis Lange, et al.
Pharmaceutical Statistics|November 21, 2018
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapiesSteffen Unkel, Marjan Amiri, Norbert Benda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2018
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-NetMarlieke E A de Kraker, Harriet Sommer, Femke de Velde, et al.
Blood Advances|October 5, 2024
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in GermanyAysenur Arslan, Svenja Labuhn, Elisa Sala, et al.
European Heart Journal|January 29, 2019
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trialMartina Rothenbühler, Marco Valgimigli, Ayodele Odutayo, et al.
Pageof 12